BTC Options 24h Volume
Aggregate 24-hour volume across listed BTC options.
Observation timeline
market observations · selected coverage below
Displayed coverage: 22 Aug 2026 to 13 Oct 2026. MAX means all available stored observations, not a promise of ten years for every asset. Observation dates are spaced by elapsed time. Lines connect available observations; intermediate values are unknown.
Accessible recent observations
| Date (UTC) | Value | Provider |
|---|---|---|
| 13 Oct 2026 00:45 | 16,601.2 BTC contracts | Deribit |
| 13 Oct 2026 00:30 | 16,547.9 BTC contracts | Deribit |
| 13 Oct 2026 00:15 | 16,539.3 BTC contracts | Deribit |
| 13 Oct 2026 00:10 | 16,518.1 BTC contracts | Deribit |
| 13 Oct 2026 00:00 | 16,200.3 BTC contracts | Deribit |
| 12 Oct 2026 23:45 | 16,119.1 BTC contracts | Deribit |
| 12 Oct 2026 23:30 | 16,200.1 BTC contracts | Deribit |
| 12 Oct 2026 23:15 | 16,177.1 BTC contracts | Deribit |
| 12 Oct 2026 23:00 | 16,068.4 BTC contracts | Deribit |
| 12 Oct 2026 22:45 | 15,934.5 BTC contracts | Deribit |
| 12 Oct 2026 22:30 | 15,929 BTC contracts | Deribit |
| 12 Oct 2026 22:15 | 15,827.6 BTC contracts | Deribit |
| 12 Oct 2026 22:00 | 15,856.4 BTC contracts | Deribit |
| 12 Oct 2026 21:45 | 15,627.5 BTC contracts | Deribit |
| 12 Oct 2026 21:30 | 15,614.6 BTC contracts | Deribit |
| 12 Oct 2026 21:15 | 15,614 BTC contracts | Deribit |
| 12 Oct 2026 21:00 | 15,521.9 BTC contracts | Deribit |
| 12 Oct 2026 20:45 | 15,237.7 BTC contracts | Deribit |
| 12 Oct 2026 20:30 | 15,256.1 BTC contracts | Deribit |
| 12 Oct 2026 20:15 | 15,204.9 BTC contracts | Deribit |
Primary source: open provider source ↗
What this chart does — and does not — claim.
Values are provider observations stored with their original observation dates. Missing dates are not interpolated. A plotted line connects available observations for visual orientation; it is not a claim that unobserved intermediate values are known.
Return to the connected intelligence desks.
Historical series support context; published conclusions remain behind the separate evidence and human-review workflow.